Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;29(23):2212-4.
doi: 10.1080/14786419.2014.1002404. Epub 2015 Jan 27.

Evaluation of Flavonols and Derivatives as Human Cathepsin B Inhibitor

Affiliations

Evaluation of Flavonols and Derivatives as Human Cathepsin B Inhibitor

Suelem D Ramalho et al. Nat Prod Res. .

Abstract

Cathepsin B (catB) is a cysteine protease involved in tumour progression and represents a potential therapeutic target in cancer. Among the 15 evaluated extracts from cerrado biome, Myrcia lingua Berg. (Myrtaceae) extract demonstrated to be a source of compounds with potential to inhibit catB. Using bioactivity-guided fractionation, we have found flavonols as inhibitors and also some other derivatives were obtained. From the evaluated compounds, myricetin (5) and quercetin (6) showed the most promising results with IC50 of 4.9 and 8.2 μM, respectively, and mode of inhibition as uncompetitive on catB. The results demonstrated polyhydroxylated flavonols as promising inhibitors of catB.

Keywords: cathepsin B; flavonoids; uncompetitive inhibitor.

Similar articles

See all similar articles

Cited by 2 articles

Publication types

LinkOut - more resources

Feedback